(Q40265316)

English

Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D.

scientific article published on 19 June 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D. (English)

1 reference

Europe PubMed Central

19 September 2017

author name string

Hui L

1

1 reference

Europe PubMed Central

19 September 2017

Zheng Y

2

1 reference

Europe PubMed Central

19 September 2017

Yan Y

3

1 reference

Europe PubMed Central

19 September 2017

Bargonetti J

4

1 reference

Europe PubMed Central

19 September 2017

Foster DA

5

1 reference

Europe PubMed Central

19 September 2017

language of work or name

0 references

publication date

19 June 2006

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

25

1 reference

Europe PubMed Central

19 September 2017

55

1 reference

Europe PubMed Central

19 September 2017

7305-7310

1 reference

Europe PubMed Central

19 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209735

0 references

P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Phospholipase D confers rapamycin resistance in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Alternative phospholipase D/mTOR survival signal in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Gain of function mutations in p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Participation of p53 cellular tumour antigen in transformation of normal embryonic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Phosphatidic acid-mediated mitogenic activation of mTOR signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Targeting Phospholipase D-mediated Survival Signals in Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

mTOR-dependent suppression of protein phosphatase 2A is critical for phospholipase D survival signals in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Lessons from hereditary colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

'Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

The IARC TP53 database: new online mutation analysis and recommendations to users

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Tumor-derived p53 mutant C174Y is a gain-of-function mutant which activates the fos promoter and enhances colony formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Modulation of gene expression by tumor-derived p53 mutants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Role for phospholipase D in receptor-mediated endocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Phospholipase D prevents apoptosis in v-Src-transformed rat fibroblasts and MDA-MB-231 breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Physical and Functional Interaction between p53 Mutants and Different Isoforms of p73

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

21 January 2018

Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

7 January 2021

based on heuristic

inferred from DOI database lookup

Dynamin is required for the activation of mitogen-activated protein (MAP) kinase by MAP kinase kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of the biological activities of wild-type and mutant p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209735

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1209735

1 reference

Europe PubMed Central

19 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40265316&oldid=1487946776"